India to United States: Ertapenem Export Trade Route

The India to United States Ertapenem corridor is one of India's established pharmaceutical export routes, with 276 shipments documented worth a combined $41.7M USD. The route is dominated by EUGIA PHARMA SPECIALITIES LIMITED, which alone accounts for roughly 76% of all export value, reflecting the consolidated nature of India's ertapenem manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $151.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with ertapenem's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 33.8%, placing it at rank #9 among India's top ertapenem export destinations globally.

On the import side, key buyers of Indian ertapenem in United States include EUGIA US LLC, EUGIA US LLC,, EVERSANA LIFE SCIENCE SERVICES and 9 others. EUGIA US LLC is the single largest importer with 111 shipments valued at $15.5M USD.

India's ertapenem exports to United States are driven primarily by a handful of large-scale manufacturers. EUGIA PHARMA SPECIALITIES LIMITED with 228 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, DR.REDDY'S LABORATORIES LTD, GLAND PHARMA LTD — together account for 89% of total trade value on this route. The average shipment value of $151.2K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as ertapenem for injection 1 g/vial(ertapen and ertapenem for injection 1g/vial 20ml vial, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, EUGIA US LLC is the largest importer with 111 shipments worth $15.5M USD — representing 37% of all ertapenem imports from India on this route. A total of 12 buyers are active on this corridor.